Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
In today’s dynamic, customizable wellness landscape, brands have a unique opportunity to stay ahead of the curve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback